GreenMark’s dental treatments will be developed in partnership with University of Michigan, which has backed the company’s two-tranche seed round through its Mints Fund.
GreenMark Biomedical, a US-based dental treatment technology developer partly based on University of Michigan research, has closed its $1.2m seed round with a $670,000 second tranche backed by the university’s Michigan Investment in New Technology Startups (Mints) fund.
The second tranche also includes contributions from Red Cedar Ventures, a $5m VC subsidiary of Michigan State University’s nonprofit affiliate Michigan State University Foundation, and from state government-backed agency Invest Michigan.
Western Michigan University’s Biosciences Research & Commercialization Center…